These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15225480)

  • 21. Serological markers in diagnosis of pediatric inflammatory bowel disease and as predictors for early tumor necrosis factor blocker therapy.
    Olbjørn C; Cvancarova Småstuen M; Thiis-Evensen E; Nakstad B; Vatn MH; Perminow G
    Scand J Gastroenterol; 2017 Apr; 52(4):414-419. PubMed ID: 27887202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auto-antibodies in patients with inflammatory bowel disease unclassified.
    Mutar Mahdi B
    Iran J Immunol; 2011 Sep; 8(3):189-94. PubMed ID: 21931206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH
    Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Bansi DS; Chapman RW; Fleming KA
    Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perinuclear antineutrophil cytoplasmic autoantibodies in dogs infected with various vector-borne pathogens and in dogs with immune-mediated hemolytic anemia.
    Karagianni AE; Solano-Gallego L; Breitschwerdt EB; Gaschen FP; Day MJ; Trotta M; Wieland B; Allenspach K
    Am J Vet Res; 2012 Sep; 73(9):1403-9. PubMed ID: 22924722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serological diagnosis of inflammatory bowel disease.
    Rutgeerts P; Vermeire S
    Lancet; 2000 Dec 23-30; 356(9248):2117-8. PubMed ID: 11191535
    [No Abstract]   [Full Text] [Related]  

  • 28. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.
    Olives JP; Breton A; Hugot JP; Oksman F; Johannet C; Ghisolfi J; Navarro J; Cézard JP
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):142-8. PubMed ID: 9252899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary on "pANCA positivity predicts lower clinical response to infliximab therapy among patients with IBD".
    Leung E
    South Med J; 2015 Mar; 108(3):144. PubMed ID: 25772046
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Reese GE; Constantinides VA; Simillis C; Darzi AW; Orchard TR; Fazio VW; Tekkis PP
    Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is antibody testing for inflammatory bowel disease clinically useful?
    Panaccione R; Sandborn WJ
    Gastroenterology; 1999 Apr; 116(4):1001-2; discussion 1002-3. PubMed ID: 10092326
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of perinuclear antineutrophil granulocytes cytoplasmic antibodies in the diagnosis of vasculitis and chronic inflammatory diseases].
    Franssen CF; Hoorntje SJ; Kallenberg CG; Gans RO
    Ned Tijdschr Geneeskd; 1996 Oct; 140(42):2076-82. PubMed ID: 8965949
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antineutrophil cytoplasmatic antibodies and their diagnostic significance as serum markers].
    Terjung B; Spengler U; Sauerbruch T
    Dtsch Med Wochenschr; 1999 Nov; 124(44):1314-20. PubMed ID: 10596294
    [No Abstract]   [Full Text] [Related]  

  • 34. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
    Mokrowiecka A; Gasiorowska A; Malecka-Panas E
    Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ANCA in inflammatory bowel disease.
    Ozaki S
    J Gastroenterol; 2000; 35(9):721-3. PubMed ID: 11023046
    [No Abstract]   [Full Text] [Related]  

  • 36. Perinuclear Antineutrophil Cytoplasmic Antibody with a Large Portion Being Anti-β-Glucuronidase, May Have Played a Causative Role in the Pathogenesis of Inflammatory Bowel Disease.
    Qin X
    Inflamm Bowel Dis; 2016 Nov; 22(11):E41-E42. PubMed ID: 27618502
    [No Abstract]   [Full Text] [Related]  

  • 37. The diagnostic accuracy of serologic markers in children with IBD: the West Virginia experience.
    Elitsur Y; Lawrence Z; Tolaymat N
    J Clin Gastroenterol; 2005 Sep; 39(8):670-3. PubMed ID: 16082274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy.
    Terjung B; Worman HJ; Herzog V; Sauerbruch T; Spengler U
    Clin Exp Immunol; 2001 Oct; 126(1):37-46. PubMed ID: 11678897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring life before IBD.
    De Vroey B; Gower-Rousseau C; Colombel JF
    Gut; 2013 May; 62(5):662-3. PubMed ID: 22936675
    [No Abstract]   [Full Text] [Related]  

  • 40. [Advances in the study on the etiology and pathogenesis of inflammatory bowel diseases].
    Lu D; Liu X; Jia B
    Zhonghua Nei Ke Za Zhi; 1996 Dec; 35(12):836-8. PubMed ID: 9592309
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.